Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Regulator of telomere elongation helicase 1 (RTEL1) is an essential DNA helicase of the XPD family involved in the maintenance of telomere length and genome stability[2][5]. RTEL1 plays a critical role in resolving secondary DNA structures such as G-quadruplexes and t-loops at telomeres, facilitating telomere extension by telomerase, and supporting DNA replication and repair in both telomeric and nontelomeric regions[1][2][6]. Mutations in the RTEL1 gene cause telomere-related disorders such as Hoyeraal-Hreidarsson syndrome, characterized by accelerated telomere shortening, bone marrow failure, immunodeficiency, and developmental defects[1][3]. RTEL1 is also implicated in the pathogenesis of certain cancers and other diseases associated with genomic instability and defective telomere maintenance[5][6]. Experimental data show that expression levels of RTEL1 must be finely regulated; excess expression can be toxic to cells, likely due to disruption of telomere homeostasis[1][3]. No known drugs currently target RTEL1 directly, but its function may be relevant in the context of telomere biology-focused therapies and as a biomarker for telomere syndromes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Regulator of telomere elongation helicase 1 (RTEL1).